Skip to main content

Table 2 The association between hyperthyroidism and major breast cancer risk predictors in KARMA cohort (N = 67,518)

From: Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors

Variable names

No. of non-hyperthyroidism

No. of hyperthyroidism

OR1 (95% CI)

OR2 (95% CI)

Benign breast disease

 No

47,345

451

1.00 (REF)

1.00 (REF)

 Yes

13,820

135

1.03 (0.85–1.24)

1.01 (0.83–1.22)

Number of births

 0

7836

78

1.00 (REF)

1.00 (REF)

 1

9032

96

1.07 (0.79–1.44)

1.07 (0.79–1.45)

 2

29,471

296

1.01 (0.79–1.30)

1.03 (0.80–1.33)

 > 2

15,245

130

0.86 (0.65–1.14)

0.86 (0.65–1.14)

Age at first birth*(years)

 < 25

18,167

206

1.00 (REF)

1.00 (REF)

 25–29

19,023

161

0.75 (0.61–0.92)

0.78 (0.63–0.97)

 ≥ 30

16,536

155

0.83 (0.67–1.02)

0.90 (0.71–1.14)

Breastfeeding duration* (months)

  < 1

4557

60

1.00 (REF)

1.00 (REF)

 1–6

19,276

210

0.83 (0.62–1.10)

0.86 (0.64–1.15)

  > 6

29,220

249

0.65 (0.49–0.86)

0.73 (0.54–0.98)

BMI (kg/cm2) category

 < 18.5

639

6

1.03 (0.46–2.32)

1.03 (0.46–2.33)

 18.5–25

34,076

310

1.00 (REF)

1.00 (REF)

 25–30

19,518

188

1.06 (0.88–1.27)

1.03 (0.86–1.24)

 > 30

7974

96

1.32 (1.05–1.67)

1.28 (1.01–1.61)

Family history of breast cancer

 No

51,994

495

1.00 (REF)

1.00 (REF)

 Yes

7809

77

1.04 (0.81–1.32)

1.02 (0.80–1.30)

Oral contraceptive use

 No

12,162

128

1.00 (REF)

1.00 (REF)

 Yes

49,271

471

0.91 (0.75–1.11)

0.95 (0.78–1.16)

Hormone replacement therapy use

 No

43,867

414

1.00 (REF)

1.00 (REF)

 Yes

17,269

180

1.10 (0.93–1.32)

0.99 (0.82–1.20)

Age at menarche (years)

 < 12

20,998

217

1.00 (REF)

1.00 (REF)

 13–16

36,565

345

0.91 (0.77–1.08)

0.92 (0.77–1.09)

 > 16

2966

30

0.98 (0.67–1.44)

0.97 (0.66–1.43)

Menopausal status

 Pre-menopausal

27,283

225

1.00 (REF)

1.00 (REF)

 Peri-menopausal

3753

40

1.29 (0.92–1.81)

1.29 (0.90–1.86)

 Post-menopausal

35,830

387

1.31 (1.11–1.54)

1.36 (1.02–1.81)

History of irregular menstrual periods

 No

53,603

520

1.00 (REF)

1.00 (REF)

 Yes

7113

75

1.09 (0.85–1.39)

1.11 (0.87–1.42)

  1. OR1 was calculated using a univariate model while OR2 was calculated with a multivariate model including all risk predictors simultaneously. The analysis was restricted to KARMA women who had not had a breast cancer diagnosis when they entered the study
  2. OR odds radio, BMI body mass index
  3. *Analyses for age at first birth and breastfeeding duration were limited to parous women